Marbotis 3mg/ml + 10mg/ml + 1mg/ml Ear Drops, Suspension for Dogs

None.

Special precautions for use in animals
Use of the product should be based on identification and susceptibility testing of
the target pathogen(s). If this is not possible, therapy should be based on
epidemiological information and knowledge of susceptibility of the target
pathogens at farm level, or at local/regional level. Use of the product should be
in accordance with official, national and regional antimicrobial policies.
An antibiotic with a lower risk of antimicrobial resistance selection (lower AMEG
category) should be used for first line treatment where susceptibility testing
suggests the likely efficacy of this approach.
Before treating with the veterinary medicinal product, the integrity of the
tympanic membrane must be verified.
The external ear canal should be meticulously cleaned and dried before
treatment.
Quinolone class drugs have been associated with cartilage erosions in
weightbearing joints and other forms of arthropathy in immature animals of
various species. The use of the veterinary medicinal product in young animals
is not recommended.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
People with known hypersensitivity to marbofloxacin, dexamethasone,
clotrimazole should avoid contact with the veterinary medicinal product.
This veterinary medicinal product may cause skin and eye irritation. Avoid
contact with skin and eyes. In case of accidental contact, wash exposed area
thoroughly with water.
Wash hands after use.

Issued: September 2024
AN: 03310/2022
In case of accidental ingestion or if skin and eye symptoms persist seek
medical advice immediately and show the package leaflet or the label to the
physician.
Special precautions for the protection of the environment
Not applicable.
Other precautions
Not applicable.